Beryl Drugs Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|
| Revenue | 6.29 | 3.21 | 7.66 |
| Operating Expense | 5.30 | 3.18 | 6.86 |
| Net Profit | 0.37 | -0.35 | 0.31 |
| Net Profit Margin | 5.88 | -10.90 | 4.05 |
| Earning Per Share | 0.73 | -0.68 | 0.61 |
| EBIDTA | 1 | 0.03 | 0.84 |
| Effective Tax Rate | 14.14 | -233.33 | 13.75 |
| Particulars | Jun 2024 |
|---|---|
| Revenue | 6.29 |
| Operating Expense | 5.30 |
| Net Profit | 0.37 |
| Net Profit Margin | 5.88 |
| Earning Per Share | 0.73 |
| EBIDTA | 1.00 |
| Effective Tax Rate | 14.14 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|
| Total Revenue Annual | 26.89 | 14.60 | 14.09 |
| Operating Expenses Annual | 24.94 | 14.20 | 12.65 |
| Operating Profit Annual | 2.21 | 0.57 | 2.08 |
| Interest Annual | 0.42 | 0.44 | 0.46 |
| Depreciation | 0.81 | 1.09 | 1.27 |
| Net Profit Annual | 0.77 | -0.66 | 0.24 |
| Tax Annual | 0.22 | -0.29 | 0.11 |
| Particulars | Mar 2023 |
|---|---|
| Total Revenue Annual | 26.89 |
| Operating Expenses Annual | 24.94 |
| Operating Profit Annual | 2.21 |
| Interest Annual | 0.42 |
| Depreciation | 0.81 |
| Net Profit Annual | 0.77 |
| Tax Annual | 0.22 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.27 | 0.45 | 0.40 |
| Cash Flow from Operations | 2.48 | -0.29 | 0.34 |
| Cash Flow from Investing | -1.30 | 0.54 | 0.26 |
| Cash Flow from Financing | -1.17 | -0.43 | -0.54 |
| Cash Flow at the End | 0.28 | 0.27 | 0.45 |
| Particulars | Mar 2023 |
|---|---|
| Cash Flow at the Beginning | 0.27 |
| Cash Flow from Operations | 2.48 |
| Cash Flow from Investing | -1.30 |
| Cash Flow from Financing | -1.17 |
| Cash Flow at the End | 0.28 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|
| PBDIT Margin (%) | 8.44 | 4.11 | 11.64 |
| PBIT Margin (%) | 5.43 | -3.36 | 2.63 |
| PBT Margin (%) | -6.14 | 3.97 | -2.98 |
| Net PROFIT Margin (%) | 2.86 | -4.52 | 1.70 |
| Return On Networth / Equity (%) | 10.03 | -8.67 | -1.29 |
| Return On Networth /Employed (%) | 11.25 | -3.72 | 2.79 |
| Return On Assets (%) | 5.93 | -5.02 | 1.81 |
| Total Debt / Equity (X) | 0.64 | 0.68 | 0.67 |
| Asset Turnover Ratio (%) | 2.07 | 1.11 | 1.06 |
| Particulars | Mar 2023 |
|---|---|
| PBDIT Margin (%) | 8.44 |
| PBIT Margin (%) | 5.43 |
| PBT Margin (%) | -6.14 |
| Net PROFIT Margin (%) | 2.86 |
| Return On Networth / Equity (%) | 10.03 |
| Return On Networth /Employed (%) | 11.25 |
| Return On Assets (%) | 5.93 |
| Total Debt / Equity (X) | 0.64 |
| Asset Turnover Ratio (%) | 2.07 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|
| Fixed Assets Annual | 5.81 | 5.86 | 7.33 |
| Total Current Assets Annual | 10.32 | 10.63 | 10.15 |
| Non Current Assets Annual | 7.20 | 7.20 | 8.50 |
| Total Shareholders Funds Annual | 8.07 | 7.29 | 7.93 |
| Total Assets Annual | 17.51 | 17.82 | 18.65 |
| Particulars | Mar 2023 |
|---|---|
| Fixed Assets Annual | 5.81 |
| Total Current Assets Annual | 10.32 |
| Non Current Assets Annual | 7.20 |
| Total Shareholders Funds Annual | 8.07 |
| Total Assets Annual | 17.51 |
No Data Availabe
